T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.29% |
| 2 | Technology | 17.01% |
| 3 | Financials | 16.32% |
| 4 | Consumer Discretionary | 14.01% |
| 5 | Industrials | 10.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVRO
1476
DELISTED
NEVRO CORP.
NVRO
| $3.35M | ﹤0.01% |
48,553
+36,595
| +306% | +$2.93M |
|
|
PMBC
1477
DELISTED
Pacific Mercantile Bancorp
PMBC
| $3.32M | ﹤0.01% |
379,739
-16,000
| -4% | -$147K |
|
1478
Arista Networks
ANET
$254B
| $3.32M | ﹤0.01% |
225,536
-2,128
| -0.9% | -$28.5K |
|
1479
Cabot Corp
CBT
$4.45B
| $3.31M | ﹤0.01% |
53,741
-13,790
| -20% | -$828K |
|
1480
Gentex
GNTX
$4.99B
| $3.29M | ﹤0.01% |
157,246
+9,390
| +6% | +$187K |
|
|
DPLO
1481
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $3.27M | ﹤0.01% |
162,788
-5,350
| -3% | -$105K |
|
|
CIT
1482
DELISTED
CIT Group Inc.
CIT
| $3.26M | ﹤0.01% |
66,162
-4,878
| -7% | -$237K |
|
1483
Fate Therapeutics
FATE
$301M
| $3.21M | ﹤0.01% |
+525,607
| New | +$2.35M |
|
1484
Avnet
AVT
$7.93B
| $3.21M | ﹤0.01% |
81,023
+675
| +0.8% | +$27K |
|
|
LSXMA
1485
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $3.21M | ﹤0.01% |
112,022
+32,217
| +40% | +$971K |
|
1486
Corvus Pharmaceuticals
CRVS
$1.25B
| $3.17M | ﹤0.01% |
306,216
+300
| +0.1% | +$3.84K |
|
1487
National Fuel Gas
NFG
$7.75B
| $3.13M | ﹤0.01% |
57,029
+5,600
| +11% | +$320K |
|
|
Y
1488
DELISTED
Alleghany Corp
Y
| $3.1M | ﹤0.01% |
5,201
+310
| +6% | +$177K |
|
|
IRS
1489
IRSA Inversiones y Representaciones
IRS
$1.25B
| $3.09M | ﹤0.01% |
108,485
+12,148
| +13% | +$329K |
|
1490
AGNC Investment
AGNC
$13.1B
| $3.07M | ﹤0.01% |
152,276
+30,599
| +25% | +$629K |
|
|
TAHO
1491
DELISTED
Tahoe Resources Inc
TAHO
| $3.03M | ﹤0.01% |
632,192
-873,455
| -58% | -$4.11M |
|
|
SYRS
1492
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $3.02M | ﹤0.01% |
30,996
+130
| +0.4% | +$17.5K |
|
|
OA
1493
DELISTED
Orbital ATK, Inc.
OA
| $3.01M | ﹤0.01% |
22,874
-2,884
| -11% | -$383K |
|
1494
Reinsurance Group of America
RGA
$16.2B
| $3.01M | ﹤0.01% |
19,284
+331
| +2% | +$50.1K |
|
|
CTRL
1495
DELISTED
Control4 Corporation
CTRL
| $3M | ﹤0.01% |
100,859
-3,310
| -3% | -$103K |
|
|
SKX
1496
DELISTED
Skechers
SKX
| $2.99M | ﹤0.01% |
78,930
-3,330
| -4% | -$108K |
|
|
P
1497
DELISTED
Pandora Media Inc
P
| $2.96M | ﹤0.01% |
614,044
+161,654
| +36% | +$968K |
|
1498
Ovid Therapeutics
OVID
$517M
| $2.96M | ﹤0.01% |
299,570
-62,070
| -17% | -$570K |
|
1499
Essential Utilities
WTRG
$11.5B
| $2.92M | ﹤0.01% |
74,429
-12,030
| -14% | -$439K |
|
1500
American Financial Group
AFG
$12.1B
| $2.91M | ﹤0.01% |
26,790
-2,049
| -7% | -$215K |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Technology and Financials.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.